← All trials
NCT04649879
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 3, 2020
- Primary completion
- Feb 1, 2022
- Completion date
- Feb 1, 2022
- First posted
- Dec 2, 2020
- Last posted
- Dec 2, 2020
- Enrollment
- 920
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Karolinska InstituteLead sponsor
- Danderyds HospitalCollaborator
- Karolinska InstituteSponsor investigator
- Karolinska InstituteCollaborator
- Falu HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.